A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)
PHASE4
This is an efficacy and safety study to compare aprepitant with ondansetron...
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic Chemotherapy
PHASE3
This phase III, multicenter, randomized, open-label trial evaluates whether...
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)
PHASE2
The purpose of this study was to determine the appropriate dosing regimen o...
Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting
NA
The purpose of this study is to clarify whether distal-proximal point assoc...
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
PHASE2
Researchers are looking for new ways to treat metastatic nonsquamous non-sm...
Status
Recruiting
Location
University of Kentucky Chandler Medical Center ( Site 0019)